Floatz logo

Eloxatin

Cholangiocarcinoma of the Gallbladder

University of ChicagoPhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cholangiocarcinoma of the Gallbladder cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
University of Chicago
Phase 2B
Calcium folinate pentahydrate
University of Chicago
Phase 2B
Cediranib
National Cancer Institute (NCI)
Phase 2CCC
Ixabepilone
National Cancer Institute (NCI)
Phase 2CCC
CIS-DIAMMINEDICHLOROPLATINUM II
Mayo Clinic
Phase 1CC

View all 15 →

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →